1. In non-valvular atrial fibrillation (NVAF) patients taking DOACs, adding amiodarone, diltiazem, dronedarone, or verapamil does not increase ischemic stroke...
1. The FDA approved rilzabrutinib, branded Wayrilz, as the first BTK (Bruton’s tyrosine kinase) inhibitor for adults with ITP (immune...
![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-350x250.png)
Novo’s srRNA push expands cardiometabolic pipeline On August 28, Novo Nordisk announced a collaboration with Replicate Bioscience to pursue self...
1. In pretreated patients with nucleophosmin 1-mutated (NPM1m) acute myeloid leukemia (AML), nearly half of patients treated with revumenib showed...
1. Curry and colleagues tested an artificial intelligence (AI) software that guided non-radiology specialists in diagnosing proximal deep vein thrombosis...
1. Hemoglobin response was significantly greater in the treatment group compared to placebo. 2. Majority of adverse events were mild...
1. Recurrent ischemic stroke rates were significantly reduced in patients who started DOAC within 4 days of an acute ischemic...
1. Higher red cell distribution width to albumin ratio (RAR) values were associated nonlinearly with a higher mortality risk. 2....
1. In this prospective cohort study, a single intravenous dose of scAAV2/8-LP1-hFIXco gene therapy in men with severe hemophilia B...
1. This case series identified three non-coding erythropoietin (EPO) variants that significantly increased gene expression under hypoxic conditions. 2. The...
